Results 121 to 130 of about 1,336,644 (348)
Responsible exit of humanitarian aid agencies at the end of programmes: a scoping review protocol. [PDF]
BMJ Open, 2023 Bahati D, Sy H, Kalhor A, Marchal B.
europepmc +1 more source
PICALM::MLLT10 translocated leukemia
FEBS Letters, EarlyView.This comprehensive review of PICALM::MLLT10 translocated acute leukemia provides an in‐depth review of the structure and function of CALM, AF10, and the fusion oncoprotein (1). The multifaceted molecular mechanisms of oncogenesis, including nucleocytoplasmic shuttling (2), epigenetic modifications (3), and disruption of endocytosis (4), are then ...
John M. Cullen +7 more
wiley +1 more source
The Dynamics of Humanitarian Diplomacy During Wartime: Insights from Tigray Crisis in Ethiopia
Social SciencesThis study examines the role of humanitarian diplomacy during the Tigray humanitarian crisis in Ethiopia, a humanitarian disaster marked by severe shortages in food, healthcare, and essential services that deeply affect civilians.
Mulubrhan Atsbaha Geremedhn +1 more
doaj +1 more source
Characteristics of humanitarian aid in a developed country: Israel Defense Force's experience from the Türkiye -Syria earthquake. [PDF]
J Glob Health, 2023 Nitecki M, Ohayon S, Almog O.
europepmc +1 more source
Cell wall target fragment discovery using a low‐cost, minimal fragment library
FEBS Letters, EarlyView.LoCoFrag100 is a fragment library made up of 100 different compounds. Similarity between the fragments is minimized and 10 different fragments are mixed into a single cocktail, which is soaked to protein crystals. These crystals are analysed by X‐ray crystallography, revealing the binding modes of the bound fragment ligands.
Kaizhou Yan +5 more
wiley +1 more source
FEBS Letters, EarlyView.Bone metastasis in prostate cancer (PCa) patients is a clinical hurdle due to the poor understanding of the supportive bone microenvironment. Here, we identify stearoyl‐CoA desaturase (SCD) as a tumor‐promoting enzyme and potential therapeutic target in bone metastatic PCa.
Alexis Wilson +7 more
wiley +1 more source
β‐TrCP overexpression enhances cisplatin sensitivity by depleting BRCA1
Molecular Oncology, EarlyView.Low levels of β‐TrCP (Panel A) allow the accumulation of BRCA1 and CtIP, which facilitate the repair of cisplatin‐induced DNA damage via homologous recombination (HR) and promote tumor cell survival. In contrast, high β‐TrCP expression (Panel B) leads to BRCA1 and CtIP degradation, impairing HR repair, resulting in persistent DNA damage and apoptosis ...
Rocío Jiménez‐Guerrero +8 more
wiley +1 more source
A simulation approach for collaborative humanitarian aid distribution management: the case of Bogotá city. [PDF]
Heliyon, 2022 Guzmán-Cortés DC +3 more
europepmc +1 more source
Molecular Oncology, EarlyView.PARP inhibitors are used to treat a small subset of prostate cancer patients. These studies reveal that PARP1 activity and expression are different between European American and African American prostate cancer tissue samples. Additionally, different PARP inhibitors cause unique and overlapping transcriptional changes, notably, p53 pathway upregulation.
Moriah L. Cunningham +21 more
wiley +1 more source